查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771575

肥胖数位健康市场规模、份额和趋势分析报告：按组件、最终用途、地区和细分市场预测，2025 年至 2033 年

Digital Health For Obesity Market Size, Share & Trends Analysis Report By Component, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

肥胖数位健康市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球肥胖数位健康市场预计到2033年将达到3928.9亿美元，2025年至2033年的复合年增长率为24.0%。

全球肥胖率不断上升，影响超过19亿成年人，这催生了对体重管理解决方案的庞大市场需求。久坐不动和不健康的饮食习惯等生活方式的改变，对这一增长贡献巨大。人们对肥胖相关健康风险（例如糖尿病和心血管疾病）的认识不断提高，促使人们寻求有效的干预措施。此外，技术进步以及数位健康解决方案、个人化饮食建议应用程式和穿戴式装置的兴起，正鼓励更多人利用科技手段进行体重管理，进一步推动市场成长。健康意识、技术创新以及对有效体重管理解决方案的迫切需求共同推动着市场的成长。

此外，肥胖市场数位健康解决方案的成长归因于肥胖及相关健康状况的日益增长以及人们健康意识的不断增强。人工智慧 (AI) 和机器学习 (ML) 等先进技术的融入预计将进一步促进市场扩张。市场上出现了各种减重应用程序，它们可在 iOS 和 Android 等各种作业系统上运行。这些应用程式涵盖生活方式监测、食物追踪、体重管理和运动监测等各个方面。全球肥胖趋势日益加剧，从而增加了对减重应用程式的需求。

此外，受新冠疫情影响，肥胖数位健康市场对远距患者管理 (RPM) 的接受度有所提升。便捷易用的工具降低了治疗门槛，并消除了经常面对面问诊的需要。 RPM 使医疗专业人员能够持续监测患者并及时提供远距协助，这对于行动不便和日程繁忙的患者来说非常有利。这种经济高效且便捷的方法能够有效管理体重，促进更高的参与度和个人化医疗服务。

市场上的主要企业专注于产品塑造和扩大影响力，采用联盟、併购、伙伴关係和产品发布等策略。例如，2023 年 10 月，专注于使用人工智慧组织医疗资讯的新兴企业Mendel.ai 推出了人工智慧平台 Hypercube。该创新系统整合了结构化和非结构化文字数据，使分析民主化，并允许使用者以自由文本形式提出问题。然后，Hypercube 提供来自特定患者数据的结果，使医疗资讯分析更易于存取和高效。 2023 年 5 月，Noom, Inc. 推出了 Noom Med，旨在对抗肥胖这种疾病。 Noom Med 将一系列远距远端医疗服务与 Noom 的个人化心理工具相结合，以促进永续减重。该计划是该公司广泛使用的消费者解决方案 Noom Weight 的延伸，它利用心理学原理、人工协助和技术来帮助患者克服可持续减重的障碍。

肥胖数位健康市场报告重点

  • 按组成部分划分，服务部门在 2024 年占据了最大的市场收益占有率。这种增长归因于对安装、维护、培训和其他服务的需求不断增长。
  • 根据最终用途，预计患者部分将在 2024 年占据最大的市场占有率，并在预测期内以最快的复合年增长率成长。
  • 2024 年，北美占据市场主导地位，收益占有率超过 37.7%。这是由于医疗保健 IT 支出的增加、适当的数位基础设施的可用性、技术进步以及新兴企业的兴起。

目录

第一章调查方法与范围

第二章执行摘要

3. 肥胖数位健康市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 肥胖数位健康市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
  • 市场新技术趋势
  • 市场技术格局
  • 案例研究分析
  • 特定国家的法规和报销情况
  • 价值链分析
  • 市场资金筹措/投资场景
    • 创业投资（VC）交易活动
    • 2024年十大数位健康创投交易
    • 年度股权资金筹措和交易
    • 季度股权资金筹措和交易
    • 全球各地区季度资金筹措及交易状况
    • 全球各地区季度交易占比
    • 按投资者群体分類的季度交易明细
    • 年度平均和中位数交易规模
    • 全球各地区平均年度交易规模
    • 投资者群体的年度平均交易规模
    • 年度大型资金筹措和交易
    • 季度资金筹措和巨额融资交易
    • 全球各地区季度巨额资金筹措及交易状况
    • 全球各地区季度巨额融资交易情况
    • 每季巨额融资资金筹措
    • 季度股票交易
    • 各交易阶段的年度交易率
    • 各季度区域交易份额（依交易阶段划分）
    • 各交易阶段的年平均资金筹措额
    • 季度种子/天使交易
    • 季度 A 轮交易
    • 季度 B 轮交易
    • 季度 C 轮交易
    • 季度 D 轮交易
    • 季度 E+ 系列交易
  • 数位健康独角兽公司的资金筹措趋势
    • 每季新增独角兽数量和总合
    • 季度新独角兽公司（按地区划分）及全球公司总合
    • 全球各地区每季新独角兽数量
    • 季度独角兽估值
  • 数位医疗市场的退出趋势
    • 年度退休福利
    • 季度退出趋势
    • 全球各地区季度离职率
    • 季度併购退出趋势
    • 季度IPO
  • 数位健康领域主要投资者分析
    • 按每季公司数量分類的投资者
    • 每季创投公司数量
    • 企业创投（CVC）以每季公司数量划分
  • 数位健康市场的主要区域投资趋势
    • 美国趋势
    • 亚洲趋势
    • 中国
    • 日本
    • 欧洲趋势
    • 英国

第四章肥胖数位健康市场：各组成部分的估计和趋势分析

  • 定义和范围
  • 2024 年及 2033 年各组件市场占有率
  • 细分仪表板
  • 肥胖数位健康市场：各组成部分的展望
  • 软体
  • 硬体
  • 服务

第五章肥胖数位健康市场：按最终用途的估计和趋势分析

  • 定义和范围
  • 2024 年和 2033 年按最终用途分類的市场占有率
  • 细分仪表板
  • 肥胖数位健康市场：按最终用途分類的展望
  • 病人
  • 医疗保健专业人员
  • 医疗保健付款人
  • 其他的

第六章肥胖数位健康市场：按地区估计和趋势分析

  • 2024 年及 2033 年各地区市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 按地区进行的 SWOT 分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 2024年主要企业市场分析
  • List of Companies
    • WW International
    • MyFitnessPal Inc.
    • Teladoc
    • FitnessKeeper
    • Healthify (My Diet Coach)
    • PlateJoy
    • Tempus
    • Fitbit, Inc.
    • Noom
    • WellDoc
    • Sidekick Health
    • BioAge Labs
Product Code: GVR-4-68040-255-7

Digital Health For Obesity Market Growth & Trends:

The global digital health for obesity market size is estimated to reach USD 392.89 billion by 2033, registering a CAGR of 24.0% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising global obesity rates, with over 1.9 billion adults affected, have created a substantial market demand for weight management solutions. Lifestyle changes, including sedentary habits and unhealthy dietary choices, contribute significantly to this growth. The increasing awareness of obesity-related health risks, such as diabetes and cardiovascular diseases, propels individuals toward seeking effective interventions. In addition, advancements in technology and the emergence of digital health solutions, personalized dietary guidance apps, and wearable devices, further drive market growth as people increasingly turn to technology for managing their weight. The intersection of health consciousness, technological innovation, and the urgent need for effective weight management solutions collectively fuels the market growth.

Furthermore, the growth of digital health solutions in obesity market can be attributed to a rising prevalence of obesity and associated health conditions, alongside growing health awareness. Incorporating advanced technologies such as artificial intelligence (AI) and machine learning (ML) is anticipated to further contribute to market expansion. Various weight loss apps are being launched in that market that offer applications on various operating systems, including iOS, Android, and others. These apps cater to various aspects such as lifestyle monitoring, diet tracking, weight management, exercise monitoring, and more. As obesity rates continue to rise globally, there is an increasing demand for weight loss apps, and companies are leveraging this trend to their advantage.

Furthermore, the digital health obesity market has witnessed increased acceptance of remote patient management (RPM) due to the impact of the COVID-19 pandemic. Implementing convenient and accessible tools has diminished obstacles to care, eliminating the necessity for frequent in-person visits. RPM allows healthcare professionals to consistently monitor patients and provide timely remote assistance, proving advantageous for individuals with limited mobility or hectic schedules. This cost-effective and convenient approach enables effective weight management and promotes heightened engagement and personalized healthcare.

The major players operating in the market are adopting strategies such as collaborations, mergers and acquisitions, and partnerships, product launches, with a major focus on enhancing product formation and reach. For instance, in October 2023, Mendel.ai, a startup specializing in the utilization of artificial intelligence for organizing medical information, unveiled Hypercube, an AI-powered platform. This innovative system integrates both structured and unstructured text data, democratizing analytics and enabling users to pose questions in free text. Hypercube then provides outcomes derived from specific patient data, enhancing accessibility and efficiency in medical information analysis. In May 2023, Noom, Inc. introduced Noom Med, designed to combat obesity as a disease. Noom Med integrates a range of telehealth services with Noom's personalized psychological tools to facilitate enduring weight loss. This program, an augmentation of Noom Weight, the company's widely used consumer-facing solution, utilizes psychological principles, human assistance, and technology to empower patients in overcoming obstacles to sustained weight loss.

Digital Health For Obesity Market Report Highlights:

  • Based on component, the services segment accounted for the largest market revenue share in 2024. This growth can be attributed to the growing demand for installation, maintenance, training, and other services.
  • Based on end-use, the patient segment accounted with the largest market share in 2024 and is anticipated to witness at the fastest CAGR over the forecast period.
  • North America dominated the market in 2024 with a revenue share of over 37.7%, owing to growing healthcare IT expenditure, availability of adequate digital infrastructure, technological advancements, the emergence of startups.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Component
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. End Use outlook.
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Health for Obesity Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of digital technology in obesity care
      • 3.2.1.2. Increasing use of artificial intelligence (AI), internet of things (IoT), and big data
      • 3.2.1.3. Growing adoption of mobile health applications and technologies
      • 3.2.1.4. Increasing burden of mental disorders
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns
      • 3.2.2.2. Lack of healthcare infrastructure
  • 3.3. Digital Health for Obesity Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Emerging Technological Trends in the Market
  • 3.5. Technology Landscape in the Market
  • 3.6. Case Study Analysis
  • 3.7. Regulatory and Reimbursement Scenario, by Country
  • 3.8. Value Chain Analysis
  • 3.9. Market Funding/Investment Scenario
    • 3.9.1. Venture capital (VC) deal activity
    • 3.9.2. Top 10 digital health VC deals in 2024
    • 3.9.3. Annual equity funding & deals
    • 3.9.4. Quarterly equity funding & deals
    • 3.9.5. Quarter funding & deals by global region
    • 3.9.6. Percent of quarterly deals by global region
    • 3.9.7. Percent of quarterly deals by investor group
    • 3.9.8. Annual average & median deal size
    • 3.9.9. Annual median deal size by global region
    • 3.9.10. Annual median deal size by investor group
    • 3.9.11. Annual mega-round funding & deals
    • 3.9.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
    • 3.9.13. Quarter mega-round funding & deals by global region
    • 3.9.14. Quarterly mega-round deals by global region
    • 3.9.15. Quarterly mega-rounds as percentage of funding
    • 3.9.16. Quarter top equity deals
    • 3.9.17. Annual percentage of deals by deal stage
    • 3.9.18. Quarter regional deal shares by deal stage
    • 3.9.19. Annual median funding by deal stage
    • 3.9.20. Quarter top seed/angel deals
    • 3.9.21. Quarter top series A deals
    • 3.9.22. Quarter top series B deals
    • 3.9.23. Quarter top series C deals
    • 3.9.24. Quarter top series D deals
    • 3.9.25. Quarter top series E+ deals
  • 3.10. Unicorn Funding Trends in Digital Health
    • 3.10.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
    • 3.10.2. Quarter new & total unicorns by global region
    • 3.10.3. Quarterly new unicorns by global region
    • 3.10.4. Quarter top unicorns by valuation
  • 3.11. Exit Trends in Digital Health Market
    • 3.11.1. Annual exits
    • 3.11.2. Quarterly exits
    • 3.11.3. Percent of quarterly exits by global region
    • 3.11.4. Quarter top M&A exits
    • 3.11.5. Quarter top IPOs
  • 3.12. Key Investors Analysis in the Digital Health Landscape
    • 3.12.1. Quarter top investors by company count
    • 3.12.2. Quarter top VCs by company count
    • 3.12.3. Quarter top corporate VCs (CVCs) by company count
  • 3.13. Key Investment Geographic Trends in Digital Health Market
    • 3.13.1. U.S. Trends
      • 3.13.1.1. Annual funding & deals
      • 3.13.1.2. Quarterly funding & deals
      • 3.13.1.3. Annual percentage of deals by deal stage
      • 3.13.1.4. Quarter top equity deals
      • 3.13.1.5. Annual exits
      • 3.13.1.6. Quarterly exists
      • 3.13.1.7. Quarter top investors by company count
    • 3.13.2. Asia Trends
      • 3.13.2.1. Annual funding & deals
      • 3.13.2.2. Quarterly funding & deals
      • 3.13.2.3. Annual percentage of deals by deal stage
      • 3.13.2.4. Quarter top equity deals
      • 3.13.2.5. Annual exits
      • 3.13.2.6. Quarterly exists
      • 3.13.2.7. Quarter top investors by company count
    • 3.13.3. China
    • 3.13.4. Japan
    • 3.13.5. Europe Trends
      • 3.13.5.1. Annual funding & deals
      • 3.13.5.2. Quarterly funding & deals
      • 3.13.5.3. Annual percentage of deals by deal stage
      • 3.13.5.4. Quarter top equity deals
      • 3.13.5.5. Annual exits
      • 3.13.5.6. Quarterly exists
      • 3.13.5.7. Quarter top investors by company count
    • 3.13.6. UK

Chapter 4. Digital Health for Obesity Market: Component Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Component Market Share, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Digital Health for Obesity Market by Component Outlook
  • 4.5. Software
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Hardware
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Services
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Digital Health for Obesity Market: End Use Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Digital Health for Obesity Market by End Use Outlook
  • 5.5. Patients
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Providers
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Payers
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Digital Health for Obesity Market: Regional Estimates & Trend Analysis, By Component, By End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. SWOT Analysis, by Region
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Singapore
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Key company market position analysis, 2024
  • 7.4. List of Companies
    • 7.4.1. WW International
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. MyFitnessPal Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Teladoc
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FitnessKeeper
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Healthify (My Diet Coach)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. PlateJoy
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Tempus
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Fitbit, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Noom
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. WellDoc
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Sidekick Health
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. BioAge Labs
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 6 U.S. digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 8 Canada digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Europe digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 10 Europe digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 11 Europe digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Germany digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 13 Germany digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 14 UK digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 15 UK digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 16 France digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 17 France digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 18 Italy digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 19 Italy digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Spain digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 21 Spain digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Denmark digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 23 Denmark digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Sweden digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 25 Sweden digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Norway digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 27 Norway digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Asia Pacific digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 31 China digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 32 China digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Japan digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 34 Japan digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 35 India digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 36 India digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 37 South Korea digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 38 South Korea digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Australia digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 40 Australia digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Singapore digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 42 Singapore digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 45 Latin America digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Brazil digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 47 Brazil digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Mexico digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 49 Mexico digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Argentina digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 51 Argentina digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 52 MEA digital health for obesity market, by region, 2021 - 2033 (USD Million)
  • Table 53 MEA digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 54 MEA digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 55 South Africa digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 56 South Africa digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 59 UAE digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 60 UAE digital health for obesity market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Kuwait digital health for obesity market, by component, 2021 - 2033 (USD Million)
  • Table 62 Kuwait digital health for obesity market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Digital health for obesity market: market outlook
  • Fig. 9 Digital health for obesity competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Digital health for obesity market driver impact
  • Fig. 13 Digital health for obesity market restraint impact
  • Fig. 14 Digital health for obesity market: Component movement analysis
  • Fig. 15 Digital health for obesity market: Component outlook and key takeaways
  • Fig. 16 Software market estimates and forecast, 2021 - 2033
  • Fig. 17 Hardware market estimates and forecast, 2021 - 2033
  • Fig. 18 Services market estimates and forecast, 2021 - 2033
  • Fig. 19 Digital health for obesity market: End use movement analysis
  • Fig. 20 Digital health for obesity market: End use outlook and key takeaways
  • Fig. 21 Patients market estimates and forecast, 2021 - 2033
  • Fig. 22 Providers market estimates and forecast, 2021 - 2033
  • Fig. 23 Payers market estimates and forecast, 2021 - 2033
  • Fig. 24 Others market estimates and forecast, 2021 - 2033
  • Fig. 25 Global digital health for obesity market: Regional movement analysis
  • Fig. 26 Global digital health for obesity market: Regional outlook and key takeaways
  • Fig. 27 Global digital health for obesity market share and leading players
  • Fig. 28 North America: SWOT
  • Fig. 29 Europe SWOT
  • Fig. 30 Asia Pacific SWOT
  • Fig. 31 Latin America SWOT
  • Fig. 32 MEA SWOT
  • Fig. 33 North America, by country
  • Fig. 34 North America
  • Fig. 35 North America market estimates and forecasts, 2021 - 2033
  • Fig. 36 U.S.
  • Fig. 37 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 38 Canada
  • Fig. 39 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 40 Europe, by country
  • Fig. 41 Europe
  • Fig. 42 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 43 UK
  • Fig. 44 UK market estimates and forecasts, 2021 - 2033
  • Fig. 45 Germany
  • Fig. 46 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 47 France
  • Fig. 48 France market estimates and forecasts, 2021 - 2033
  • Fig. 49 Italy
  • Fig. 50 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 51 Spain
  • Fig. 52 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 53 Denmark
  • Fig. 54 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 55 Sweden
  • Fig. 56 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 57 Norway
  • Fig. 58 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 59 Asia Pacific, by country
  • Fig. 60 Asia Pacific
  • Fig. 61 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 62 China
  • Fig. 63 China market estimates and forecasts, 2021 - 2033
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 66 India
  • Fig. 67 India market estimates and forecasts, 2021 - 2033
  • Fig. 68 Singapore
  • Fig. 69 Singapore market estimates and forecasts, 2021 - 2033
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 74 Latin America, by country
  • Fig. 75 Latin America
  • Fig. 76 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 77 Brazil
  • Fig. 78 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 79 Mexico
  • Fig. 80 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 81 Argentina
  • Fig. 82 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 83 Middle East and Africa, by country
  • Fig. 84 Middle East and Africa
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 88 Saudi Arabia
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 90 UAE
  • Fig. 91 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 92 Kuwait
  • Fig. 93 Kuwait market estimates and forecasts, 2021 - 2033